Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210035102 210013283 1.6 66.5 Palliative (P) 2019-11-09 2019-11-10 Ofatumumab Loading 2 N 210039734 TAMIGA TRIAL
210035103 210013285 null 63 Palliative (P) 2014-06-12 2014-06-16 DAUNORUBICIN + VINCRISTINE Y Y 210039746 CISPLATIN
210035104 210013290 1.74 null Curative (C) 2016-02-04 2016-03-14 BEAM null N 210039757 GEMCARBO
210035105 210013297 0 82 Curative (C) 2019-03-08 2019-03-08 Cytarabine intrathecal N N 210039787 BCG
210035106 210013315 1.58 93 Curative (C) 2016-12-28 2016-12-28 CARBO + ETOPOSIDE + VINCRISTINE Y N 210039899 TAMIGA TRIAL
210035107 210036186 null 78 Curative (C) 2014-11-29 2014-12-04 Maintenance Therapy ALL N N 210039963 CISPLATIN + ETOPOSIDE
210035108 210013347 null 50 Curative (C) 2016-07-22 2016-11-30 Nilotinib N null 210040057 CARBOPLATIN + LOMUSTINE + VINCRISTINE
210035109 210013358 1.68 null null 2015-12-11 2015-12-29 Cyclophos + Dex + Lenalidomide N null 210040136 DOXORUBICIN
210035110 210013378 null 77 Palliative (P) 2016-04-05 2016-04-26 Cetuximab + Radiotherapy Maint N null 210040336 TAMIGA TRIAL
210035111 210013381 1.69 64.1 Palliative (P) 2016-03-10 2016-07-08 Packer Induction Vincristine + RT Y N 210040383 RMS 2005 TRIAL
210035112 210022393 1.65 135 Curative (C) 2017-03-22 2017-10-15 Eribulin N N 210040419 BEVACIZUMAB + LOMUSTINE
210035113 210031489 1.85 null Adjuvant (A) 2010-11-02 2013-12-02 BUSULFAN + FLUDARABINE + METHOTREXATE Y N 210040494 DARATUMUMAB
210035114 210013417 1.57 72 Curative (C) 2017-09-22 2017-11-04 Cytarabine intrathecal 1 N 210040628 ICE
210035115 210022420 1.52 null Curative (C) 2017-02-05 2017-03-15 CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine N N 210040696 ICE
210035116 210013433 1.65 10.8 Curative (C) 2016-12-08 2016-12-09 Abiraterone N N 210040699 SIOP
210035117 210013441 0.85 52.3 Curative (C) null 2014-02-16 IPILIMUMAB + NIVOLUMAB 02 Y 210040728 DOXORUBICIN
210035118 210022437 1.77 38 Palliative (P) 2016-01-28 2016-01-31 ICE (no GCSF) N N 210040880 BEVACIZUMAB + IRINOTECAN
210035119 210013482 0 null Disease modification (D) 2018-03-12 2018-06-15 CVP 2 Y 210040958 ABVD
210035120 210013491 0 90.5 Curative (C) 2014-07-26 2014-08-30 IGEV R 02 null 210041021 BR14 TRIAL
210035121 210013507 1.72 98.2 Curative (C) 2016-09-22 2016-09-22 FLAG N null 210041101 IDARUBICIN
210035122 210013513 1.74 109.85 Curative (C) 2015-04-14 2015-04-24 Cytarabine Intrathecal (any age) 02 null 210041122 CAPECITABINE
210035123 210013518 1.71 null Curative (C) 2017-11-23 2017-11-23 Capecitabine + Oxaliplatin 21day N N 210041191 BEVACIZUMAB + TEMOZOLOMIDE
210035124 210013527 1.64 54.7 Palliative (P) 2019-05-06 2019-05-06 ALEMTUZUMAB + CYCLOPHOSPHAMIDE + METHOTREXATE N N 210041199 AML17 TRIAL
210035125 210013547 0.85 null Palliative (P) 2016-09-23 2016-09-30 Epirubicin N N 210041346 REGORAFENIB
210035126 210013549 1.64 84.6 Curative (C) 2016-09-30 2016-11-09 Gemcitabine weekly Y N 210041357 CARBOPLATIN + PACLITAXEL
210035127 210022480 1.75 100 Curative (C) 2014-11-26 2014-12-04 Carboplatin + Pemetrexed N N 210041423 TAMIGA TRIAL
210035128 210033674 1.64 118.3 Adjuvant (A) 2015-05-02 2015-11-15 CNS LGG Irinotecan & Bevacizumab N N 210041470 SIOP
210035129 210022496 1.89 18.1 Palliative (P) 2015-06-19 2015-07-22 IMMUNOGLOBULIN 02 N 210041630 ALL
210035130 210022508 1.88 117.5 Disease modification (D) 2019-05-01 2019-11-14 Ofatumumab Weekly N null 210041817 FLUDARABINE + MELPHALAN
210035131 210022512 null 83.5 Disease modification (D) null 2016-04-06 Cyclophosphamide High Dose null null 210041854 CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE
210035132 210013631 0 65.5 Curative (C) 2016-02-24 2016-02-24 Carboplatin + Paclitaxel (weekly) 2 N 210041861 CYTARABINE
210035133 210013644 null 82.6 Curative (C) 2018-02-28 2018-04-24 CLL210 TRIAL null null 210041983 OBINUTUZUMAB
210035134 210022531 1.73 65.9 Curative (C) 2016-05-24 2016-09-23 ALL Int Guide B Int Maint Ph III null N 210042069 VINORELBINE
210035135 210013663 1.81 null Curative (C) 2017-01-20 2017-01-20 AML17 TRIAL 02 N 210042133 LENALIDOMIDE
210035136 210013668 0 null Disease modification (D) 2018-03-12 2018-03-12 CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE N Y 210042147 CYTARABINE + ETOPOSIDE
210035137 210013673 1.91 70.2 Curative (C) 2018-09-05 2018-12-05 Phase 2 Induction (ALL) 2 N 210000284 RUXOLITINIB
210035138 210022543 0 52.1 null 2019-11-19 2019-12-12 Nilotinib N N 210004103 UKALL2003
210035139 210022549 null 99.7 Palliative (P) 2018-06-27 2018-07-11 Bortezomib (weekly) N null 210008796 UKALL2003
210035140 210022554 1.7 null Curative (C) 2017-11-09 2017-11-09 Bevacizumab + Irinotecan N N 210011848 SUNITINIB
210035141 210022555 1.83 98.9 null 2019-06-23 2019-07-01 CLARITY Trial N null 210012655 CYCLOPHOSPHAMIDE + ETOPOSIDE + NELARABINE
210035142 210013709 1.71 91.2 Curative (C) 2018-05-15 2018-12-19 Alemtuzumab + Cyclophos TBI Allo N null 210021324 IDARUBICIN
210035143 210013714 1.82 99.2 Disease modification (D) 2017-12-30 2018-02-26 CISPLATIN + ETOPOSIDE 02 N 210021743 AML18 TRIAL
210035144 210013722 null 102.7 Curative (C) 2016-08-04 2016-08-06 Nilotinib 2 N 210022095 ALEMTUZUMAB + CYCLOPHOSPHAMIDE + METHOTREXATE
210035145 210022576 1.87 88 Disease modification (D) 2017-10-04 2017-10-04 DAUNORUBICIN + VINCRISTINE N N 210023716 CYCLO + FLUDARABINE + RITUXIMAB
210035146 210022588 1.78 27.5 Neo-adjuvant (N) 2013-07-25 2016-11-16 MERCAPTOPURINE + METHOTREXATE + VINCRISTINE N N 210025389 CYCLOPHOSPHAMIDE + CYTARABINE + ETOPOSIDE + METHOTREXATE + NELARABINE
210035147 210022595 1.68 82.3 Curative (C) 2019-01-30 2019-02-21 PENTOSTATIN + RITUXIMAB N null 210026674 CYTARABINE HD + METHOTREXATE HD
210035148 210013775 0 112.8 Curative (C) 2019-09-19 2019-09-27 Cytarabine intrathecal N N 210027899 LENALIDOMIDE
210035149 210013781 null 83.4 null 2019-12-11 2019-12-19 CAV 2 N 210028000 GDP R
210035150 210013782 null 35.5 Palliative (P) 2015-09-11 2015-09-26 MELPHALAN N N 210028065 ESHAP R
210035151 210013786 1.69 null Curative (C) 2018-04-20 2018-04-24 BR14 TRIAL Y N 210028705 ICE-R